80 related articles for article (PubMed ID: 35714859)
1. Deletion of Lactate Dehydrogenase-A Impairs Oncogene-Induced Mouse Hepatocellular Carcinoma Development.
Serra M; Di Matteo M; Serneels J; Pal R; Cafarello ST; Lanza M; Sanchez-Martin C; Evert M; Castegna A; Calvisi DF; Mazzone M; Columbano A
Cell Mol Gastroenterol Hepatol; 2022; 14(3):609-624. PubMed ID: 35714859
[TBL] [Abstract][Full Text] [Related]
2. METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression.
Xia P; Zhang H; Lu H; Xu K; Jiang X; Jiang Y; Gongye X; Chen Z; Liu J; Chen X; Ma W; Zhang Z; Yuan Y
Cancer Commun (Lond); 2023 Mar; 43(3):338-364. PubMed ID: 36602428
[TBL] [Abstract][Full Text] [Related]
3. Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
Sun J; Ding J; Shen Q; Wang X; Wang M; Huang Y; Zhang X; Zhu H; Zhang F; Wu D; Peng M; Zhang Z; Yuan Y; Li W; She ZG; Zhang XJ; Li H; Zhang P; Huang Z
J Hepatol; 2023 Mar; 78(3):627-642. PubMed ID: 36462680
[TBL] [Abstract][Full Text] [Related]
4. LSD1 interacting with HSP90 promotes skin wound healing by inducing metabolic reprogramming of hair follicle stem cells through the c-MYC/LDHA axis.
Li S; Yu J; Zhang J; Li X; Yu J
FASEB J; 2023 Jul; 37(7):e23031. PubMed ID: 37342917
[TBL] [Abstract][Full Text] [Related]
5. Metabolic rearrangements and intratumoral heterogeneity for immune response in hepatocellular carcinoma.
Xu FQ; Dong MM; Wang ZF; Cao LD
Front Immunol; 2023; 14():1083069. PubMed ID: 36776894
[TBL] [Abstract][Full Text] [Related]
6. PFKFB3-mediated Pro-glycolytic Shift in Hepatocellular Carcinoma Proliferation.
Dou Q; Grant AK; Callahan C; Coutinho de Souza P; Mwin D; Booth AL; Nasser I; Moussa M; Ahmed M; Tsai LL
Cell Mol Gastroenterol Hepatol; 2023; 15(1):61-75. PubMed ID: 36162723
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses.
Foglia B; Beltrà M; Sutti S; Cannito S
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108625
[TBL] [Abstract][Full Text] [Related]
8. Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression.
Khan F; Lin Y; Ali H; Pang L; Dunterman M; Hsu WH; Frenis K; Grant Rowe R; Wainwright DA; McCortney K; Billingham LK; Miska J; Horbinski C; Lesniak MS; Chen P
Nat Commun; 2024 Mar; 15(1):1987. PubMed ID: 38443336
[TBL] [Abstract][Full Text] [Related]
9. Metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer.
Liu J; Zhang C; Zhang T; Chang CY; Wang J; Bazile L; Zhang L; Haffty BG; Hu W; Feng Z
Nat Metab; 2022 Dec; 4(12):1830-1846. PubMed ID: 36536137
[TBL] [Abstract][Full Text] [Related]
10. Glutamine metabolic reprogramming in hepatocellular carcinoma.
Ye Y; Yu B; Wang H; Yi F
Front Mol Biosci; 2023; 10():1242059. PubMed ID: 37635935
[TBL] [Abstract][Full Text] [Related]
11. NOP2-mediated m5C Modification of c-Myc in an EIF3A-Dependent Manner to Reprogram Glucose Metabolism and Promote Hepatocellular Carcinoma Progression.
Zhang H; Zhai X; Liu Y; Xia Z; Xia T; Du G; Zhou H; Franziska Strohmer D; Bazhin AV; Li Z; Wang X; Jin B; Guo D
Research (Wash D C); 2023; 6():0184. PubMed ID: 37398932
[TBL] [Abstract][Full Text] [Related]
12. Research progress of abnormal lactate metabolism and lactate modification in immunotherapy of hepatocellular carcinoma.
Xu Y; Hao X; Ren Y; Xu Q; Liu X; Song S; Wang Y
Front Oncol; 2022; 12():1063423. PubMed ID: 36686771
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin L Regulates Metabolic Networks Controlling Rapid Cell Growth and Proliferation.
Weiss-Sadan T; Itzhak G; Kaschani F; Yu Z; Mahameed M; Anaki A; Ben-Nun Y; Merquiol E; Tirosh B; Kessler B; Kaiser M; Blum G
Mol Cell Proteomics; 2019 Jul; 18(7):1330-1344. PubMed ID: 31010818
[TBL] [Abstract][Full Text] [Related]
14. Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies.
Mossenta M; Busato D; Dal Bo M; Toffoli G
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32585931
[TBL] [Abstract][Full Text] [Related]
15. Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review.
Wang Q; Liu J; Chen Z; Zheng J; Wang Y; Dong J
Biomed Pharmacother; 2024 Jan; 170():116021. PubMed ID: 38128187
[TBL] [Abstract][Full Text] [Related]
16. Proteomic Study on Multi-Organ Metastases of Human Ovarian Clear Cell Carcinoma Cell Line in a Xenograft Mouse Model Based on a Novel Sequence-Specific Analysis Strategy.
Ye N; Li Y; Li X; Su T; Wang S; Zheng W; Yang H; Cheng J; Gong M
Front Biosci (Landmark Ed); 2023 Mar; 28(3):53. PubMed ID: 37005747
[TBL] [Abstract][Full Text] [Related]
17. LDHA: The Obstacle to T cell responses against tumor.
Tang Y; Gu S; Zhu L; Wu Y; Zhang W; Zhao C
Front Oncol; 2022; 12():1036477. PubMed ID: 36518315
[TBL] [Abstract][Full Text] [Related]
18. Characterization of tumor evolution by functional clonality and phylogenetics in hepatocellular carcinoma.
Kacar Z; Slud E; Levy D; Candia J; Budhu A; Forgues M; Wu X; Raziuddin A; Tran B; Shetty J; Pomyen Y; Chaisaingmongkol J; Rabibhadana S; Pupacdi B; Bhudhisawasdi V; Lertprasertsuke N; Auewarakul C; Sangrajrang S; Mahidol C; Ruchirawat M; Wang XW
Commun Biol; 2024 Mar; 7(1):383. PubMed ID: 38553628
[TBL] [Abstract][Full Text] [Related]
19. The switch triggering the invasion process: Lipid metabolism in the metastasis of hepatocellular carcinoma.
Zhang J; Zhang Z; Wu Z; Wang Y; Zhang Z; Xia L
Chin Med J (Engl); 2024 May; ():. PubMed ID: 38738689
[TBL] [Abstract][Full Text] [Related]
20. Sorbitol dehydrogenase induction of cancer cell necroptosis and macrophage polarization in the HCC microenvironment suppresses tumor progression.
Lee SY; Kim S; Song Y; Kim N; No J; Kim KM; Seo HR
Cancer Lett; 2022 Dec; 551():215960. PubMed ID: 36244575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
